We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Does Metabolic Syndrome Exist in Anorexia Nervosa?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00271921
Recruitment Status : Completed
First Posted : January 4, 2006
Last Update Posted : December 18, 2012
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary:
The purpose of this study is to examine whether body fat distribution changes that occur with weight gain in women recovering from anorexia nervosa are transient or persistent, and if they are associated with other features of Metabolic Syndrome.

Condition or disease Intervention/treatment
Anorexia Nervosa Metabolic Syndrome Behavioral: Calorie controlled diet

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Does Metabolic Syndrome Exist in Anorexia Nervosa?
Study Start Date : September 2005
Primary Completion Date : June 2007
Study Completion Date : June 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • DSM-IV diagnosis of Anorexia Nervosa (except amenorrhea) (restricting or binge eating/purging subtype)
  • Female
  • Age 18-40
  • Medically stable
  • Participation in inpatient or daypatient treatment sufficient to restore patient to a BMI of at least 19.5kg/m²

Exclusion Criteria:

  • Additional Major Axis I disorder (including substance abuse or dependence
  • On daily prescription medication (including oral contraceptives)
  • History of suicide attempt or other self-injurious behavior within the previous 6 months
  • Significant current or past medical illness,including diabetes mellitus, heart disease
  • Indwelling metallic object (e.g., pacemaker,pump), non-removable metal jewelry or recent metallic ink tattoo

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00271921


Locations
United States, New York
St. Luke's Roosevelt Hosptial Center
New York, New York, United States, 10025
New York State Psychiatric Institute/Columbia University
New York, New York, United States, 10032
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Laurel Mayer, MD New York State Psychiatric Institute/Columbia University
Principal Investigator: Henry Ginsberg, MD Columbia University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00271921     History of Changes
Other Study ID Numbers: R03 DK66033 (completed)
First Posted: January 4, 2006    Key Record Dates
Last Update Posted: December 18, 2012
Last Verified: December 2012

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
eating disorders
anorexia nervosa
body fat distribution
metabolic syndrome
visceral adipose tissue

Additional relevant MeSH terms:
Syndrome
Metabolic Syndrome X
Anorexia
Anorexia Nervosa
Disease
Pathologic Processes
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Signs and Symptoms, Digestive
Signs and Symptoms
Feeding and Eating Disorders
Mental Disorders